alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                   Exhibit 32(b)

                    CERTIFICATION OF CEO AND CFO PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Consumers Energy Company
(the "Company") for the annual period ended December 31, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), David W.
Joos, as Chief Executive Officer of the Company, and Thomas J. Webb, as
Executive Vice President and Chief Financial Officer of the Company, each hereby
certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:

            (1) The Report fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

            (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

   /s/ David W. Joos
-------------------------------
Name:  David W. Joos
Title: Chief Executive Officer
Date:  March 10, 2005

   /s/ Thomas J. Webb
-------------------------------
Name:  Thomas J. Webb
Title: Executive Vice President and
       Chief Financial Officer
Date:  March 10, 2005
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                             832
<SECURITIES>                                         0
<RECEIVABLES>                                    3,144
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 9,797
<PP&E>                                         795,238
<DEPRECIATION>                                (24,731)
<TOTAL-ASSETS>                                 801,474
<CURRENT-LIABILITIES>                           22,160
<BONDS>                                        395,600
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           217
<OTHER-SE>                                     331,040
<TOTAL-LIABILITY-AND-EQUITY>                         0
<SALES>                                              0
<TOTAL-REVENUES>                                54,733
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                36,214
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               8,907
<INCOME-PRETAX>                                 16,295
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    16,295
<EPS-PRIMARY>                                      .74
<EPS-DILUTED>                                      .74
        

</TABLE>
[Federal Register Volume 82, Number 176 (Wednesday, September 13, 2017)]
[Notices]
[Pages 43028-43029]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-19363]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Board of Scientific 
Counselors, NHLBI.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Heart, Lung, and Blood Institute, including consideration of personnel 
qualifications and

[[Page 43029]]

performance, and the competence of individual investigators, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Board of Scientific Counselors, NHLBI.
    Date: October 23-24, 2017.
    Time: October 23, 2017, 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health Building 10, 10 Center 
Drive, 6th Floor, Room 6S233, Bethesda, MD 20892.
    Time: October 24, 2017, 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health Building 10, 10 Center 
Drive, 6th Floor, Room 6S233, Bethesda, MD 20892.
    Contact Person: Robert S Balaban, Ph.D., Scientific Director, 
Division of Intramural Research, National Heart, Lung, and Blood 
Institute, National Institutes of Health, Building 10, 10 Center 
Drive, 6th Floor, Room 6S233, Bethesda, MD 20892, 301-496-2116, 
<a href="/cdn-cgi/l/email-protection#9dfffcf1fcfffcf3efddf3f5f1fff4b3f3f4f5b3faf2eb"><span class="__cf_email__" data-cfemail="caa8aba6aba8aba4b88aa4a2a6a8a3e4a4a3a2e4ada5bc">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: September 7, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-19363 Filed 9-12-17; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# r,) ORIGINAL

IN THE SUPREME COURT OF THE STATE OF MONTANA DA 21-0508

RANDALL KEITH ORTON,

Petitioner and Appellant, v. STATE OF MONTANA,

Respondent and Appellee. 

# FILED JAN 3 1 2023 Bowen iw000 Clork of Supreme Court State of Montana ORDER

Randall Keith Orton has filed a motion stating opposition to dismissal ofhis appeal with prejudice, which this Court has indicated will occur if Orton continues to delay his briefing. The State ofMontana has filed a response in opposition to Orton's motion. On October 26, 2021, this Court granted Orton's petition for out-of-time appeal, reasoning he had demonstrated extraordinary circumstances for an appeal ofthe Missoula County District Court's Order denying and dismissinghis petition for postconviction relief from his felony DUI conviction, entered in March 2021. We have twice denied Orton's associated motions for appointment ofcounsel on appeal because he is not entitled to such appointment under Montana law. Orton v. State,No. DA 21-0508, Order (Mont. Nov. 30, 2021); § 46-8-104, MCA. However, we have granted Orton numerous extensions oftime to file his brief. In its objection to Orton's motion, State points out that, between January 2022,when Orton's briefwas originally due, through October 2022,we granted Orton nine extensions oftime, and in theninth extension stated no furtherextensionswould be granted andthe appealwould be dismissed with prejudice ifOrton "fail[ed]to filehis openingbrief on orbeforeNovember 25,2022." Thereafter,wegrantedtwomore extensions andwarned Orton again about dismissal. His briefwas thus due on January 26, 2023, which prompts his current motion. 01/31/2023

Case Number: DA 21-0508Orton now requests that his appeal be dismissed without prejudice, and that he be

allowed to refile his appeal once he obtains counsel. The State responds that Orton should not be permitted to begin the appellate process anew, because it is not in the interest of justice. We note that Orton has also since filed another motion for extension of time, his twelfth, and his third motion for appointment ofcounsel. As both the State and this Court has noted,he represented himselfinthe District Court whenhe soughtpostconviction relief on his DUI conviction. This Court has extended considerable latitude to Orton as a selfrepresented litigant, and we cannot grant any further relief. See Greenup v. Russell, 2000 MT 154, ¶ 15, 300 Mont. 136, 3 P.3d 124. Therefore, IT IS ORDERED that: 1. Orton's Motion in Opposition to Dismissal with Prejudice is DENIED; 2. Orton's Motion for Extension ofTime and Motion for Appointment ofCounsel are both DENIED; 3. This appeal is DISMISSED WITH PREJUDICE; and 4. The Clerk of the Supreme Court is directed to CLOSE this matter as of this Order's date and to issue remittitur. The Clerk is also directed to provide a copy ofthis Order to counsel ofrecord and to Randall Keith Orton personally. DATED this 

# 3P

71—day ofJanuary, 2023. 

# 4 ,01 1,, ,gr,\? ChiefJustice

23 Justices
1 IN THE COURT OF APPEALS OF THE STATE OF IDAHO

Docket No. 43006

STATE OF IDAHO ,

Plaintiff

- Respondent ,

v.

CASEY GENE GILSON JR. ,

Defendant

- Appellant

. ) ) ) ) ) ) ) ) ) ) 2015 Unpublished Opinion No. 693

Filed: November 4, 2015

Stephen W. Kenyon, Clerk

THIS IS AN UNPUBLISHED OPINION AND SHALL NOT BE CITED AS AUTHORITY

Appeal from the District Court of the Seventh Judicial District, State of Idaho, Bonneville County. Hon. Jon J. Shindurling , District Judge.

Judgment of conviction and sentence s , affirmed

.
Sara B. Thomas, State Appellate Public Defender; Elizabeth A. Allred , Deputy Appellate Public Defender, Boise, for appellant.

Hon. Lawrence G. Wasden, Attorney General; Lori A. Fleming , Deputy Attorney General, Boise, for respondent.

________________________________________________ Before GUTIERREZ, Judge; GRATTON, Judge;

and HUSKEY, Judge

________________________________________________

PER CURIAM
Casey Gene Gilson Jr. pleaded guilty to rape of a female under the age of 16 where the
perpetrator is 18 years of age or older, I daho Code § 18

- 6101, and a violation of a no contact

order , I daho Code §§ 1 8

- 920, 18

- 920(3). The distr ict court imposed a twenty

- five

- year sentence
, with three years determinate , and a concurrent, indeterminate five

- year sentence, respectively.

Gilson appeals, contending that his sentences are excessive.
Sentencing is a mat ter for the trial court’s discretion. Both our standard of review and the
factors to be considered in evaluating the reasonableness of the sentence are well established and
need not be repeated here. See State v. Hernandez , 121 Idaho 114, 117

- 18, 822 P.2 d 1011, 1014

- 15 (Ct. App. 1991); State v. Lopez , 106 Idaho 447, 449

- 51, 680 P.2d 869, 871

- 73 (Ct. App.2

1984); State v. Toohill , 103 Idaho 565, 568, 650 P.2d 707, 710 (Ct. App. 1982). When reviewing
the length of a sentence, we consider the defendant’s ent ire sentence. State v. Oliver , 144 Idaho
722, 726, 170 P.3d 387, 391 (2007). Applying these standards, and having reviewed the record
in this case, we cannot say that the district court abused its discretion.

Therefore, Gilson ’s judgment of conviction and sentence s are affirmed.
[Federal Register Volume 82, Number 169 (Friday, September 1, 2017)]
[Notices]
[Page 41631]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18614]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Eye Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Advisory 
Eye Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Eye Council.
    Date: October 12, 2017.
    Open: 8:30 a.m. to 1:00 p.m.
    Agenda: Following opening remarks by the Director, NEI, there 
will be presentations by the staff of the Institute and discussions 
concerning Institute programs.
    Place: Fishers Lane Conference Center, 5635 Fishers Lane, 
Terrace Level Conference Rooms, Rockville, MD 20852.
    Closed: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Fishers Lane Conference Center, 5635 Fishers Lane, 
Terrace Level Conference Rooms, Rockville, MD 20852.
    Contact Person: Paul A. Sheehy, Ph.D., Director, Division of 
Extramural Affairs, National Eye Institute, National Institutes of 
Health, 5635 Fishers Lane, Suite 12300, Bethesda, MD 20892, 301-451-
2020, <a href="/cdn-cgi/l/email-protection#cfbfbcfcfda78fa1a6a7e1a8a0b9"><span class="__cf_email__" data-cfemail="c8b8bbfbfaa088a6a1a0e6afa7be">[email protected]</span></a>.

    Information is also available on the Institute's/Center's home 
page: www.nei.nih.gov, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.867, 
Vision Research, National Institutes of Health, HHS)

    Dated: August 29, 2017.
Natasha M. Copeland,
Program Analyst. Office of Federal Advisory Committee Policy.
[FR Doc. 2017-18614 Filed 8-31-17; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
EX 10.08


	
        AAddress: 665 Ellsworth Avenue

        New Haven, CT 06511, USA

        Email:uschien@uschinachannel.net

        Tel: (001) 203-844-0809; (001) 203-562-8899



ANDREW CHIEN AGENT


----EDGAR FILING SERVICE


 


 


EDGAR FILING AGENCY AGREEMENT


This Edgar Filing Agency Agreement is made and entered into as
August 14, 2011 between Andrew Chien (“Agent”) and China Northern Medical Device, Inc.(“China Northern”
or “Company”).


 


WHEREAS, Agent is an Edgar Filer in the business to do Edgar filing
for companies who is a SEC reporting company.


 


WHEREAS, CHINA NORTHERN is a SEC reporting company.


 


WHEREAS, CHINA NORTHERN wishes to utilize the services of Agent
to do Edgar filing under the term of this Agreement and Agent wishes to become the company’s file agency.


 


Now, THEREFORE, in consideration of the mutual promises herein
contained, the parties hereto hereby agree as follows:


 


1. Appointment of Agent. Upon the execution of this agreement
by both parties, CHINA NORTHERN hereby appoints Agent as Edgar Filing Agency.


 


2. Fees. Total filing service fee for one year’s 10-K and
10-Qs filing is $4000. The first down payment is $2,000 and six month later CHINA NORTHERN pay additional $2,000.


 


3. CHINA NORTHERN responsibilities:(a).Any filing document must
deliver to Agent, one week ahead of filing;(b).The document should be in Word format, all financial statement must be in Excel
format


 


4. Modification: No change, modification, addition, or amendment
to this Agreement will be valid unless in writing and signed by all parties hereto.


 


5. No Interpretation against drafter: This Agreement has been
negotiated between persons sophisticated and knowledgeable in these types of matters. Accordingly, any normal rule of construction
or legal decision that would require a court to resolve any ambiguities against the drafting party is hereby waived and shall not
apply in interpreting this Agreement.


 


6. Venue/Governing Law: Venues for all proceedings in connection
with this Agreement shall be New Haven County, Connecticut, and all aspect of this Agreement should be governed by laws of State
of Connecticut.


 


7. Termination: Any termination should issue two weeks ahead by
writing notice to another party.


Agent                        Company


/s/Andrew Chien                  CHINA NORTHERN MEDICAL DEVICE, INC.


Andrew Chien; CEO                 /s/Wujing Zhao 


Date: August 14, 2011         Wujing Zhao, president


Note: This contract was executed by China Bull Management Inc
Exhibit 31.2


I, Alexander C. Frank, Chief Financial Officer of Fifth Street Senior Floating Rate Corp., certify that:


1. I have reviewed this annual report on Form 10-K for the period ended September 30, 2013 of Fifth Street Senior Floating Rate Corp.;


2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the period presented in this report;


4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:


(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within those entities, particularly during the period in which this report is being prepared;


(b) [Omitted]


(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Dated this 25 th day of November, 2013.





By:/s/    Alexander C. FrankAlexander C. FrankChief Financial Officer
IN THE SUPREME COURT OF THE STATE OF DELAWARE

BOBBY TAYLOR

,

Defendant Below

, Appellant,

v.

STATE OF DELAWARE

,

App ellee

. §

§ No. 3 32 , 2023

§

§ Court Below : Superior Court

§ of the State of Delaware

§

§ C r. ID No. 1511017784A&B

§

§

§

Submitted:

Decided: June 5 , 2024

June 12 , 2024

Before VALIHURA

, TRAYNOR

, and GRIFFITHS

, Justices

.

ORDER

After careful consideration of the parties’ briefs and the record on appeal, we

conclude that the judgment of the Superior Court should be affirmed on the basis of

and for the reasons stated in its August 16, 2023 memorandum opinion and order

.

NOW, THEREFORE, IT IS ORDERED that th e Superior Court’s judgment

is AFFIRMED

.

BY THE COURT:

/s/ N. Christopher Griffiths

Justice
Specimen of Common Stock Certificate



 Exhibit 4.3 
 



 
 Photo Medex PHOTOMEDEX, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE SEE
REVERSE FOR CERTAIN DEFINITIONS THIS IS TO CERTIFY THAT CUSIP 719358 30 1 SPECIMEN is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF THE COMMON STOCK OF THE PAR VALUE OF $.01 PER SHARE OF PHOTOMEDEX, INC. transferable upon the books of the
Corporation by the holder hereof in person or by duly authorized attorney upon surrender of this Certificate properly endorsed. This certificate is not valid unless countersigned by the Transfer Agent. Witness the facsimile seal of the Corporation
and the facsimile signatures of its duly authorized officers. Dated: COUNTERSIGNED AND REGISTERED: STOCKTRANS, INC. 44 W. Lancaster Avenue Ardmore, PA 19003 TRANSFER AGENT AND REGISTRAR AUTHORIZED OFFICER ASSISTANT SECRETARY PHOTOMEDEX, INC.
CORPORATE SEAL 1987 DELAWARE CHIEF EXECUTIVE OFFICER BY: 







 



 
 The Corporation will furnish without charge to each stockholder who so requests a
statement of the designations, relative rights, preferences, and limitations applicable to each class of shares and the variations in rights, preferences, and limitations determined for each series thereof (and the authority of the Board of
Directors to determine variations for future series). Such request may be addressed to the Secretary of the Corporation or to the Transfer Agent and Registrar named on the face of this Certificate. The following abbreviations, when used in the
inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations: TEN COM — as tenants in common TEN ENT — as tenants by the entireties JT TEN — as
joint tenants with right of survivorship and not as tenants in common UNIF GIFT MIN ACT Custodian (Cost) (Minor) under Uniform Gifts to Minors Act (State) Additional abbreviations may also be used though not in the above list. For value received,
hereby sell, assign and transfer unto PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE (PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE OF ASSIGNEE) shares of the capital stock represented by the within
Certificate and do hereby irrevocably constitute and appoint Attorney to transfer the said stock on the books of the within named Corporation with full power of substitution in the premises. Dated NOTICE: THE SIGNATURE TO THIS ASSIGNMENT MUST
CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATEVER. Signature(s) Guaranteed: THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION
(BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C. RULE 17Ad-15.